Don C. Wiley (1944–2001)  by Bjorkman, Pamela J
Structure, Vol. 10, 139–140, February, 2002, 2002 Elsevier Science Ltd. All rights reserved. PII S0969-2126(02)00706-2
Obituary
Don C. Wiley (1944–2001)
It was with great sadness that the structural biology
community learned of the death of Don Wiley, one of
the most prominent protein crystallographers of his gen-
eration. Don’s research had a profound impact on many
fields, including virology and immunology, with a series
of elegant structural and biological studies of viruses
and the immune response against them. Don started his
scientific studies as a physics major at Tufts University,
graduating in 1966. He switched to biophysics as a grad-
uate student, joining William Lipscomb’s laboratory at
Harvard, at a time when the crystal structures of proteins
were just beginning to be elucidated at atomic resolu-
tion. As a graduate student, Don set an ambitious goal
for himself—to provide a structural explanation for the
mechanism of allosteric regulation in aspartate transcar-
bamylase, resulting in a 5.5 A˚ structure at a time when
a project of this magnitude was virtually inconceivable.
Don’s graduate studies greatly impressed his col-
leagues, for he was hired as an assistant professor at
Harvard immediately after earning his PhD in 1971. Steve with hemagglutinin, and was actively involved in the
design of compounds to inhibit viral fusion.Harrison was hired at about the same time, and the
two young crystallographers set up a joint laboratory, Don began the other major focus of his laboratory,
the study of major histocompatibility complex (MHC)sharing space, equipment, and supplies. Don soon de-
cided to concentrate on structural studies of viral pro- proteins and their recognition together with antigen by
T cell receptors, in the late 1970s as a collaboration withteins, focusing on the influenza virus hemagglutinin. He
contacted John Skehel, a British biochemist and virolo- his Harvard colleague Jack Strominger. Jack’s labora-
tory had developed a method to purify the ectodomainsgist who had shown that hemagglutinin could be re-
leased from flu virus by bromelain treatment, resulting of human class I MHC molecules from B lymphocytes,
and these presented an intriguing target for crystallo-in a collaboration and friendship that lasted the rest of
Don’s life. With guidance from John, Don learned to graphic studies. At the time, the altered self hypothesis
for MHC-restricted antigen recognition by T cells sug-grow flu virus in eggs and purify hemagglutinin, initially
on his own and later during a sabbatical year spent in gested by Rolf Zinkernagel and Peter Doherty’s studies
of T cell killing of virally infected cells raised the possibil-John’s lab at Mill Hill. This immersion in the biological
context surrounding the object of his structural studies ity that the mysterious dual recognition properties of
T cells might be understood by taking the structures ofwas to mark Don’s approach to all projects in his labora-
tory—it was not enough to solve a crystal structure of a viral antigen (e.g., hemagglutinin) and an MHC protein
(e.g., the human class I MHC molecule HLA-A2) anda protein; there had to be a reason for wanting to deter-
mine a structure, and Don’s reasons related to wanting docking them together as a complex. Of course, we
know now that T cells do not recognize intact viral anti-to answer fundamental questions involving human
health. His faith in structure as the ultimate illuminator gens complexed with MHC molecules—instead, T cell
receptors recognize peptide fragments of antigensof function was fully realized by the completion of the
hemagglutinin structure, published in 1981 by Don, John bound to MHC proteins—but at the time Don’s labora-
tory published the first MHC structure in 1987, the dis-Skehel, and Don’s first postdoc, Ian Wilson, which re-
vealed a tall trimeric protein upon which the sites of covery of a peptide occupant in the HLA-A2 binding
groove came as a big surprise. The fact that HLA-A2viral antigenic shift and the host receptor binding region
could be mapped. But the mechanism by which hemag- contained a bound peptide (or peptides) demonstrated
that T cell recognition of a virus or other pathogen inglutinin accomplished fusion of the viral and host mem-
branes remained unclear until a fusion-active structure an infected cell was a lot more subtle than simply de-
tecting the presence of a peptide antigen; since MHCwas solved by Don’s lab in 1994. This structure revealed
a remarkable conformational change, suggesting a molecules are always occupied with peptide, the T cell
has to determine whether the peptide is derived from amechanism for juxtaposing the viral and host cell mem-
branes. Don later expanded his interests to include other safe “self” protein or from a dangerous “foreign” protein.
Don followed up the HLA-A2 structure with structuresviral mediators of membrane fusion, including proteins
from HIV and Ebola virus, revealing features in common of a number of other class I and class II MHC proteins,
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many with defined bound peptides, which allowed a won’t be the same without Don. Other labs may solve
structures he would have solved, but no one else willcomplete description of the rules for peptide binding to
class I and class II MHC proteins, culminating in the first achieve these goals with the same style and level of
insight, appreciation, and awe that he had for the beautyhigh-resolution views of a T cell receptor/MHC/peptide
complex, published in 1996. revealed by protein structure.
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protein structures in particular. One of the things that
made Don’s laboratory a uniquely inspiring place to do
research was Don’s almost child-like enthusiasm for
science. I especially remember his excitement over any
new crystals, no matter how small or unpromising. This
enthusiasm carried many of us through to successful
completion of what might otherwise have seemed like
hopeless projects. In my own case, working as a gradu-
ate student and then postdoc in Don’s lab with thin
microcrystals of HLA-A2, I might have given up had it
not been for Don’s unshakable confidence that not only
would the structure be solved some day, but that when
it was solved, it would be incredibly interesting. Don
had the knack for making even the smallest step toward
solving a structure seem like a breakthrough. For exam-
ple, we spent some time analyzing the crystal packing
at a time when I was having trouble with phasing, and
Don was happy and excited to pore over the Interna-
tional Tables with me to figure out the relationship be-
tween the HLA-A2 space groups. In retrospect, this was
not really very interesting, but Don made it seem fasci-
nating. Not that working with Don was all sweetness
and light—Don enjoyed trading insults with people, and
his students were no exception. One he directed at me
stands out in my mind—I had annoyed him with some
now forgotten obnoxious graduate student behavior or
comment, and exasperated, he told me that he hoped
I would one day have a student exactly like me. I took
this as an insult, as he had meant it, but implicit in the
barb was that he was confident I would some day be
in a position to have graduate students of my own, and
it helped me through times when it seemed that I would
never even earn a PhD.
In my last conversation with Don, which took place
at a meeting that ended the day before he disappeared
in Memphis, he talked about his plans for the next 15
or so years. He had ambitious goals, such as solving
the structure of an intact T cell receptor in a membrane
with the CD3 components. He had also worked out how
he would retire. Instead of continuing to run a laboratory,
write grants, be responsible for students, etc. when he
was in his 70s, he would do his own experiments in
other people’s labs. That way he would have the fun of
doing science when he was older without all the respon-
sibilities that running a laboratory entails. I had a vision
of Don in 20 years’ time, loudly and good-naturedly
complaining about “cretins” and “toads” who had hid-
den his reagents or were trying to convince him to do
an experiment in some stupid fashion (i.e., not the way
it had been done with hemagglutinin), but having the
time of his life back at the bench again. That’s the way
it should have been. Structural virology and immunology
